ReviewJournal of hematology & oncology2013
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics.
Akintunde Akinleye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
139 papers cite itlatest 60 shown
this papercites it